Synlait Milk Limited (ASX: SM1) is a New Zealand-based dairy processing company specialising in the manufacture and export of value-added dairy products, including infant formula, nutritional powders, and consumer dairy goods. The company operates primarily from its South Island facilities, with additional operations previously located in the North Island.
Synlait’s business model focuses on supplying high-quality dairy ingredients and finished products to global customers, particularly in Asia. Its operations are supported by vertically integrated supply chains and long-standing relationships with major partners such as Bright Dairy and The a2 Milk Company.
The company has built a reputation for premium product quality and innovation within the global dairy sector, though recent performance has been impacted by operational and market challenges.
Synlait’s HY2026 result reflects a combination of operational inefficiencies and adverse market conditions. Revenue remained broadly stable, however profitability deteriorated sharply due to rising costs and weaker margins.
Gross profit turned negative, while earnings before finance costs and tax declined significantly, highlighting pressure across core business segments. The Group recorded a net loss of NZ$80.6 million, compared to a profit in the prior corresponding period.
Operating cash flow also weakened materially, with a net outflow driven by working capital movements, higher inventory levels and reduced profitability. Management attributed the result to a combination of internal operational challenges and external pricing pressures, particularly within the ingredients business.
A series of operational disruptions contributed to weaker performance during the period. Manufacturing issues in the second half of FY2025 created an inventory shortfall, requiring Synlait to prioritise rebuilding customer stock levels.
This led to adjustments in the company’s production plan, resulting in surplus milk volumes during peak season. Excess milk was sold into the market, though not all sales were successfully executed, forcing a shift in production towards lower-margin products such as whole milk powder.
At the same time, global prices for whole milk powder declined sharply in late 2025, exacerbating margin pressures and contributing to losses within the ingredients segment. The combination of operational inefficiencies and falling commodity prices created what management described as a “perfect storm” for the business.
Synlait’s financial position remains under pressure, with total borrowings increasing significantly and net debt rising during the period.
The company has secured amendments to its banking facilities, including covenant waivers and revised thresholds, to maintain compliance and support liquidity. These measures provide short-term financial flexibility while the company executes its recovery strategy.
In addition, Synlait continues to rely on shareholder support, including a substantial loan from its majority shareholder, Bright Dairy. Management has emphasised that maintaining access to capital remains a key uncertainty, though progress in refinancing discussions and asset sales provides some confidence in the Group’s ongoing viability.
A central component of Synlait’s recovery strategy is the planned divestment of its North Island operations. The sale is expected to reduce debt, improve liquidity and streamline the company’s operational focus.
Following the divestment, Synlait will concentrate on its core South Island assets, which management believes offer stronger long-term potential and operational efficiency.
The company is also undertaking broader strategic initiatives, including cost reduction measures, operational reviews and restructuring efforts aimed at improving productivity and profitability.
Synlait has introduced a three-phase recovery roadmap designed to reposition the business for sustainable growth. The strategy focuses first on stabilising operations by improving reliability, strengthening customer delivery and reinforcing financial resilience. It then aims to simplify the business by streamlining operations, reducing costs and enhancing organisational efficiency. Finally, the company intends to scale by expanding into higher-margin products, new markets and growth opportunities. Management has emphasised that improving “commercial optionality” will be critical to long-term success, enabling greater flexibility in responding to changing market conditions and customer demand.
While near-term conditions remain challenging, Synlait’s management maintains a cautiously optimistic outlook. The completion of the North Island asset sale, combined with operational improvements and cost discipline, is expected to support a gradual recovery in performance.
However, the company has withdrawn formal FY2026 guidance, reflecting ongoing uncertainty and the need to prioritise stabilisation over short-term targets.
Management has indicated that the next 12 to 24 months will be a critical period for the business, with a focus on rebuilding profitability, strengthening the balance sheet and restoring investor confidence.
Despite current challenges, Synlait believes its core assets, customer relationships and strategic initiatives position the company for improved long-term performance once operational stability is achieved.
Chifley Tower, 2 Chifley Square,
Sydney NSW 2000
1300 854 151
© 2025 KOSEC | Kodari Securities Pty Ltd | ABN 90 147 963 755 | FSG | Terms & Conditions | Disclaimer & Legal
© 2025 KOSEC | Kodari Securities Pty Ltd
ABN 90 147 963 755
KOSEC - Kodari Securities does not provide any investment advice, nor is anything mentioned an offer to sell, or a solicitation of an offer to buy any security or other instrument. Anything discussed is for informational purposes only and does not address the circumstances or needs of any particular individual or entity. Investing in the stock market is high risk. Under no circumstances should investments be based solely on the information provided. We do not guarantee the security or completeness of information on this website and are not held liable. Kodari Securities PTY Ltd trading as KOSEC is a corporate authorized representative (AFSL no.246638) which is regulated by the Australian securities and investment commission (ASIC).